This urgency has led to practices that have led some realtors and brokerages to voice concern
over risks caused by fast deals and on - the - spot million dollar decisions.
This urgency has led to practices that have led some realtors and brokerages to voice concern
over risks caused by fast deals and on - the - spot million dollar decisions.
Not exact matches
Important factors that could
cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the
risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control
over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the
risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
«If you have concerns stemming from the macro environment and that
causes risk to come out of the bond market, then that may spill
over to the equity markets,» he says.
From our definition there flows an important corollary: The riskiness of an investment is not measured by beta (a Wall Street term encompassing volatility and often used in measuring
risk) but rather by the probability — the reasoned probability — of that investment
causing its owner a loss of purchasing power
over his contemplated holding period.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the
risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the
risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the
risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the
risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the
risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the
risk that longer manufacturing lead times may
cause customers to fulfill their orders with a competitor's products instead; the
risk that the economic and political uncertainty
caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix;
risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the
risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the
risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments;
risks resulting from the concentration of our business among few customers, including the
risk that customers may reduce or cancel orders or fail to honor purchase commitments; the
risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the
risk that retail customers may alter promotional pricing, increase promotion of a competitor's products
over our products or reduce their inventory levels, all of which could negatively affect product demand; the
risk that our investments may experience periods of significant stock price volatility
causing us to recognize fair value losses on our investment; the
risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the
risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired;
risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products
risks related to our multi-year warranty periods for LED lighting products;
risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products;
risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
These
risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the
risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may
cause fluctuations in Gilead's earnings; market share and price erosion
caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may
cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the
risk that physicians and patients may not see advantages of these products
over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may
cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other
risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Trump victory will
cause short - term
risk - off and preference for Developed Markets
over Emerging Markets.
However, while the Fed's mandate does not extend to reacting to the vagaries of the currency market or the dynamics affecting other economies, recent US dollar strength and wobbles in
risk assets
caused by concerns
over the state of the Chinese economy can not be entirely ignored.
But it's essential to contain ones exuberance as regional
risk can easily entangle in higher US yields, but so far the push in treasury yields has not been intense enough to
cause a substantial adverse shift in
risk sentiment, but caution prevails as the move higher in US Bond yields could be far from
over.
«The riskiness of an investment is not measured by beta (a Wall Street term encompassing volatility and often used in measuring
risk) but rather by the probability — the reasoned probability — of that investment
causing its owner a loss of purchasing - power
over his contemplated holding period.»
Humans have razed some 20 percent of the Amazon rainforest
over the last 40 years alone, and an additional 20 percent is at
risk of being destroyed — a potentially catastrophic loss that would
cause this vital ecosystem to unravel.
This
causes significant physical stress on their bodies
over time and presents serious
risk of water contamination.
Arsenal forward Alexandre Lacazette has indirectly
risked causing a stir in a discussion
over the club's Premier League title hopes this season.
Protecting players from increased
risk of traumatic brain injury by teaching them «heads up» tackling and blocking, equipping them with properly fitted helmets, strengthening their necks to better withstand the forces that
cause concussion, and by limiting the number of hits they sustain
over the course of a season and career;
The latest study published in June 2012, showed that high school students in the United States had significant progress
over the past two decades in improving many youth
risk behaviors associated with the leading
cause of death in their age group, car crashes.
These types of crib bumpers still place your baby at
risk for rolling
over and get his or her face stuck up against the crib bumper, which can
cause suffocation.
And
over bundling your baby in these conditions can
cause sweating and even becomes a
risk factor for your baby.
In 1976, M&M candies discontinued their «Red M» amidst concerns
over the potentially fatal
risk of red food coloring that contained amaranth (in FD&C Red # 2), suspected as being cancer -
causing.
They are often promoted for consumption in menopausal women for bone density, but there is concern that
over exposure to PhytoEstrogens increases the
risk of breast cancer and
causes fertility issues.
You may also be anxious
over lupus
causing complications during your pregnancy or increasing your
risk of a miscarriage.
[31] It is a bill that would address federal adoption incentives and would amend the Social Security Act (SSA) to require the state plan for foster care and adoption assistance to demonstrate that the state agency has developed policies and procedures for identifying, documenting in agency records, and determining appropriate services with respect to, any child or youth
over whom the state agency has responsibility for placement, care, or supervision who the state has reasonable
cause to believe is, or is at
risk of being, a victim of sex trafficking or a severe form of trafficking in persons.
«Legitimate questions
over the funding provided to campaigners
risks causing harm to voters» confidence in the referendum and it is therefore right that we investigate.»
«Small spills at gas stations could
cause significant public health
risks over time.»
They also tracked Apolipoprotein E (APOE 4), a well - known genetic
risk factor for Alzheimer's, as well as lifetime cumulative exposure to unhealthy levels of PM2.5 — particles which are at least 30 times smaller than the diameter of a human hair and frequently
cause the haze
over urban areas.
Debates are now erupting
over the benefits and ecological
risks of releasing such insects into the wild — and whether gene drives could also thwart invasive species such as Asian carp and cane toads, or combat other animal - borne pathogens such as the one
causing Lyme disease.
The hormonal changes can
cause hot flashes, depression, and,
over time, contribute to women's
risk of developing dementia and osteoporosis.
The deadly fungal disease known as white - nose syndrome has spread to bat colonies throughout eastern North America
over the past seven years,
causing bat populations to crash, with several species now at
risk of extinction.
«Our findings suggest that exposures that occur before the influence of a prior message «wears off» could
cause the
risk of smoking to accumulate
over the long term,» Martino said.
«
Over the past 25 years, a woman's
risk of dying from pregnancy - related
causes has nearly halved,» said Flavia Bustreo, assistant director - general for family, women's and children's health at the World Health Organization (WHO).
Understanding its molecular
causes and
risk factors has been challenging because most cases develop sporadically without inherited genetic mutations, and because of the gradual progression of symptoms
over the course of disease.
«We've been targeting traditional
risk factors in public health campaigns for many years,» said Susan Cheng, M.D., M.P.H., study lead author and Assistant Professor of Medicine at Brigham and Women's Hospital in Boston, Mass. «We wanted to take a look at how well we've been doing
over time at keeping these
risk factors from
causing heart and vascular disease — both by preventing the
risks from occurring and by minimizing their effects when they do occur.»
«I think they're addictive, they elevate your
risks for skin cancer, and now there's the concept that they
cause a behavioral dependency — it's the nicotine story all
over again.»
He adds that the stem cells used in the study have advantages
over reprogrammed skin cells, including eliminating the tricky business of inducing the cells to become muscle cells, but he notes that both types of cells could pose
risks because the virus used to modify them could
cause cancer.
Older adults
over age 65 are at high
risk for developing pneumonia, an inflammation of the lungs typically
caused by infection.
«We suggest studies that follow users
over time and seek to answer the
cause - and - effect questions surrounding social media use and
risk for eating and body image concerns.»
Given the information we have, potentially
over a million cases of Zika
caused by mosquito transmission versus two cases of sexual transmission, the additional
risk appears small.
We estimated the
risk of death due to cardiorespiratory
causes in the general population of 65 - 69 year olds from data from the Office for National Statistics.19 We assumed that this death rate was approximately that of the non-smoking population, because around 12 % of this age group smoke.20 We multiplied this rate by the relative
risk of death from cardiorespiratory
causes in lifelong smokers to estimate the number of deaths that would be expected
over five years from cardiorespiratory
causes in the general population of 65 year olds who smoke.
For example, a study published in the Archives of Internal Medicine found that
over a nine - year period, consuming more dietary fiber lowered the
risk of death from any
cause.
In
over 34,000 post-menopausal women, intake of flavonoid - rich foods such as bran, apples, pears, grapefruit, strawberries, red wine and chocolate was associated with a lower
risk of heart disease and all -
cause deaths.
And people with the highest levels (
over 70 mg / dl) actually had an increased
risk of death from non-heart or stroke - related
causes compared to those with more middling ranges (about 41 to 60 mg / dl).
Female athletes are at
risk for common nutrient deficiencies, such as low protein, low iron, low calcium, and low vitamin D. (3) When active women don't eat enough nutrients, or they are poorly absorbed due to increased intestinal permeability (leaky gut), SIBO, SIFO, or other
causes of intestinal epithelial inflammation, they are not nourished enough to sustain intense exercise
over time.
- Elderly people with positive attitudes have an
over twenty percent reduction in
risk of death from cardiovascular disease and
over fifty percent lower
risk from all other
causes.
Pure Encapsulations has worked with herbalists all
over the world to find the purest all natural herbs to help women live through menopause without the
risk associated with pharmaceuticals in synthetic hormone replacement that inherently
cause damage and in some cases death and weaken a woman's natural abilities to overcome normal menopausal changes.
Risk of injury
caused by
over activity is reduced in any particular muscle group due to muscle imbalance.
Mastering Diabetes: Studies conducted in tens of thousands of people
over 5 + years indicate that low - carbohydrate diets increase your
risk for cardiovascular disease, hemorrhagic stroke, hypertension, atherosclerosis, diabetes mortality, obesity, cancer, and all -
cause mortality (premature death).
After adjusting for lifestyle and dietary
risk factors, a major study involving 131,342 participants found that for every 3 - percent increase in plant protein the participants worked into their diets, they saw their
risk for death from
causes including heart disease drop by 10 percent
over a 32 - year period.
One study linked a daily handful of nuts to a reduced
risk of dying from any
cause over a 30 - year period.
The cycle repeats
over and
over again, and long - term, that
causes inflammation which can seriously increase our
risk of diseases.
While the
causes are unclear, those at increased
risk are
over age 55; those with a close relative (mother, daughter or sister) with ovarian cancer; and women with a family history of breast, uterine or colon cancers, according to the Valley Health System in Ridgewood, N.J.